atorvastatin has been researched along with Arthritis, Rheumatoid in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 13 (43.33) | 29.6817 |
2010's | 14 (46.67) | 24.3611 |
2020's | 3 (10.00) | 2.80 |
Authors | Studies |
---|---|
Hehmke, B; Koch, CA; Krabbe, S | 1 |
Barreto de Melo Rêgo, MJ; Branco Pinto Duarte, AL; da Paixão, ABF; da Rocha Junior, LF; da Rocha Pitta, I; da Rocha Pitta, MG; de Oliveira, PSS; Pereira, MC | 1 |
Beers-Tas, MV; Boers, M; Bos, W; Griep, EN; Marsman, D; Nurmohamed, MT; Popa, CD; Starmans-Kool, M; Turk, S; van Boheemen, L; van Schaardenburg, D; van Sijl, A | 1 |
Dong, C; Guo, Q; Hou, J; Wang, D; Wu, L | 1 |
Li, B; Li, GM; Liu, J; Ma, JX; Ma, XL; Zhang, XF; Zhao, J | 1 |
Liao, KP; Solomon, DH | 1 |
Armitage, J; Belch, JJF; Kitas, GD; Nightingale, P; Sattar, N; Symmons, DPM | 1 |
Bradley, JD; Brosnan, MJ; Connell, CA; Kim, HY; Lee, SH; Luo, Z; Mandel, D; McInnes, IB; Song, YW; Zuckerman, A; Zwillich, SH | 1 |
Hisdal, J; Holme, I; Ikdahl, E; Kvien, TK; Pedersen, TR; Rollefstad, S; Semb, AG | 1 |
Tremoulet, AH | 1 |
Akiyama, M; Fukushi, J; Hashimura, C; Iwamoto, Y; Kishimoto, J; Kondo, M; Mawatari, T; Miyahara, H; Nakashima, Y; Okazaki, K; Yamada, H | 1 |
Berns, SA; Bondareva, IN; Smakotina, SA; Zelendinova, AR | 1 |
Ferringer, T; Lountzis, NI; Puri, PK; Tyler, W | 1 |
Kukhrchuk, VV; Nasonov, EL; Novikova, DS; Popkova, TV; Tutunov, VS | 1 |
Blaschke, S; Guerluek, S; Klinger, HM; Müller, GA; Schwarz, G; Viereck, V | 1 |
Nikitina, NM; Rebrov, AP | 1 |
Holme, I; Kvien, TK; Pedersen, TR; Semb, AG | 1 |
El-Barbary, AM; Hamouda, HE; Hussein, MS; Ismail, RG; Rageh, EM; Wagih, AA | 1 |
Cheng, X; Ding, YJ; Du, R; Jevallee, H; Liao, MY; Liao, YH; Shi, GP; Song, Y; Tang, TT; Xiao, H; Yao, R; Yu, X; Yuan, J; Zhou, ZH | 1 |
John, H; Kitas, GD; Toms, TE | 1 |
Choi, J; Kim, JY; Lee, EB; Lee, EY; Lee, YJ; Song, YW; Yoo, HJ | 1 |
Hamsten, A; Klareskog, L | 1 |
Capell, HA; Ford, I; Hampson, R; Madhok, R; McCarey, DW; McInnes, IB; Sattar, N; Scherbakov, O | 1 |
McColl, G; Van Doornum, S; Wicks, IP | 1 |
Harten, SK; Haskard, DO; Johns, M; Kinderlerer, AR; Lidington, EA; Mason, JC; Maxwell, PH; Steinberg, R | 1 |
Jansen, TL | 1 |
de Vegvar, HE; Digennaro, C; Higgins, JP; Ho, PP; Kidd, BA; Lee, LY; Robinson, WH; Steinman, L; Tomooka, B | 1 |
Ansell, BJ; Charles-Schoeman, C; Fogelman, AM; Furst, DE; Gong, T; Khanna, D; McMahon, M; Park, GS; Paulus, HE; Reddy, ST | 1 |
Bielinska, A; Gluszko, P | 1 |
4 review(s) available for atorvastatin and Arthritis, Rheumatoid
Article | Year |
---|---|
Efficacy of Atorvastatin Plus Conventional Disease-Modifying Antirheumatic Drugs on Disease Activity in Rheumatoid Arthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Atorvastatin; Humans; Randomized Controlled Trials as Topic | 2022 |
The anti-inflammatory effects of statins on patients with rheumatoid arthritis: A systemic review and meta-analysis of 15 randomized controlled trials.
Topics: Arthritis, Rheumatoid; Atorvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Randomized Controlled Trials as Topic | 2018 |
Rheumatoid arthritis: is it a coronary heart disease equivalent?
Topics: Anticholesteremic Agents; Arthritis, Rheumatoid; Atorvastatin; Coronary Disease; Diabetes Complications; Diabetes Mellitus, Type 2; Heptanoic Acids; Humans; Hyperlipidemias; Pyrroles; Risk Factors | 2011 |
[Statins--are they potentially useful in rheumatology?].
Topics: Arthritis, Rheumatoid; Atorvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lupus Erythematosus, Systemic; Osteoporosis; Pyrroles; Rheumatic Diseases; Simvastatin; Treatment Outcome | 2007 |
9 trial(s) available for atorvastatin and Arthritis, Rheumatoid
Article | Year |
---|---|
Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial.
Topics: Arthritis, Rheumatoid; Atorvastatin; Double-Blind Method; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Rheumatoid Factor | 2021 |
A Multicenter, Randomized, Placebo-Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis.
Topics: Aged; Anticholesteremic Agents; Arthritis, Rheumatoid; Atorvastatin; Cardiovascular Diseases; Cholesterol, LDL; Double-Blind Method; Female; Humans; Male; Middle Aged; Primary Prevention; Proportional Hazards Models; Treatment Outcome | 2019 |
Open-label tofacitinib and double-blind atorvastatin in rheumatoid arthritis patients: a randomised study.
Topics: Administration, Oral; Adult; Arthritis, Rheumatoid; Atorvastatin; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Male; Middle Aged; Piperidines; Placebos; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Treatment Outcome | 2014 |
[Comparative assessment of antiinflammatory action of atorvastatin in ischemic heart disease and rheumatoid arthritis].
Topics: Arthritis, Rheumatoid; Atorvastatin; C-Reactive Protein; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Ischemia; Prospective Studies; Pyrroles; Treatment Outcome | 2008 |
[The use of atorvastatin in patients with rheumatoid arthritis with hyperlipidemia].
Topics: Administration, Oral; Adult; Aged; Arthritis, Rheumatoid; Atorvastatin; C-Reactive Protein; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipids; Male; Middle Aged; Pyrroles; Treatment Outcome; Vascular Resistance | 2009 |
Effect of atorvastatin on inflammation and modification of vascular risk factors in rheumatoid arthritis.
Topics: Adiponectin; Adult; Aged; Analysis of Variance; Antirheumatic Agents; Arthritis, Rheumatoid; Atorvastatin; Drug Therapy, Combination; Endothelium, Vascular; Female; Forearm; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Lipids; Male; Methotrexate; Middle Aged; Prednisone; Pyrroles; Regional Blood Flow; Resistin; Risk Factors; Severity of Illness Index; Tumor Necrosis Factor-alpha | 2011 |
Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis.
Topics: Adult; Anticholesteremic Agents; Arthritis, Rheumatoid; Atorvastatin; Female; Heptanoic Acids; Humans; Male; Middle Aged; Pyrroles; Signal Transduction; T-Lymphocytes, Regulatory | 2011 |
Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Atorvastatin; Biomarkers; Blood Sedimentation; Blood Viscosity; C-Reactive Protein; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Male; Methotrexate; Middle Aged; Pyrroles; Risk Factors; von Willebrand Factor | 2004 |
Effects of high-dose atorvastatin on antiinflammatory properties of high density lipoprotein in patients with rheumatoid arthritis: a pilot study.
Topics: Anti-Inflammatory Agents; Anticholesteremic Agents; Arthritis, Rheumatoid; Atorvastatin; Dose-Response Relationship, Drug; Female; Heptanoic Acids; Humans; Lipoproteins, HDL; Male; Middle Aged; Pilot Projects; Pyrroles | 2007 |
17 other study(ies) available for atorvastatin and Arthritis, Rheumatoid
Article | Year |
---|---|
Effect of atorvastatin on rheumatoid arthritis-associated autoreactive T cells.
Topics: Adult; Arthritis, Rheumatoid; Atorvastatin; Humans; Male; T-Lymphocytes | 2019 |
Atorvastatin inhibits IL-17A, TNF, IL-6, and IL-10 in PBMC cultures from patients with severe rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Atorvastatin; Cells, Cultured; Cytokines; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-10; Interleukin-17; Interleukin-6; Leukocytes, Mononuclear; T-Lymphocyte Subsets; Tumor Necrosis Factors | 2020 |
Lipids and Cardiovascular Risk Through the Lens of Rheumatoid Arthritis.
Topics: Arthritis, Rheumatoid; Atorvastatin; Cardiovascular Diseases; Humans; Lipids; Primary Prevention; Risk Factors | 2019 |
Systemic inflammation in patients with inflammatory joint diseases does not influence statin dose needed to obtain LDL cholesterol goal in cardiovascular prevention.
Topics: Aged; Arthritis, Psoriatic; Arthritis, Rheumatoid; Atorvastatin; Cardiovascular Diseases; Cholesterol, LDL; Comorbidity; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Middle Aged; Rosuvastatin Calcium; Simvastatin; Spondylitis, Ankylosing | 2015 |
The role of statins in inflammatory vasculitides.
Topics: Adaptive Immunity; Adolescent; Adult; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Atorvastatin; Behcet Syndrome; Child; Child, Preschool; Clinical Trials as Topic; Drug Repositioning; Humans; Immunity, Innate; Infant; Inflammation; Mucocutaneous Lymph Node Syndrome | 2015 |
Prevalence of dyslipidemia in Japanese patients with rheumatoid arthritis and effects of atorvastatin treatment.
Topics: Aged; Arthritis, Rheumatoid; Asian People; Atorvastatin; Cholesterol, HDL; Cholesterol, LDL; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Japan; Logistic Models; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Treatment Outcome; Triglycerides | 2015 |
[Pleiotropic effects of atorvastatin in rheumatoid arthritis patients with no history of cardiovascular diseases].
Topics: Adult; Anticholesteremic Agents; Arthritis, Rheumatoid; Atorvastatin; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Female; Humans; Inflammation; Interleukin-6; Lipid Metabolism; Matrix Metalloproteinase 3; Middle Aged; Patient Acuity; Rheumatoid Factor; Treatment Outcome; Triglycerides; Tumor Necrosis Factor-alpha | 2015 |
Hydroxychloroquine-induced hyperpigmentation: the staining pattern.
Topics: Aged; Antacids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Aspirin; Atorvastatin; Calcium Carbonate; Cardiomyopathy, Restrictive; Citalopram; Connective Tissue Diseases; Diuretics; Female; Furosemide; Glucosamine; Heptanoic Acids; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperpigmentation; Lupus Erythematosus, Systemic; Magnesium; Metolazone; Middle Aged; Naproxen; Omeprazole; Potassium Chloride; Prednisone; Pyrroles; Selective Serotonin Reuptake Inhibitors; Spironolactone | 2008 |
Anti-inflammatory effects of atorvastatin on peripheral blood mononuclear cells and synovial fibroblasts in rheumatoid arthritis.
Topics: Adult; Aged; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Arthritis, Rheumatoid; Atorvastatin; Biomarkers; Case-Control Studies; CD4-Positive T-Lymphocytes; CD8 Antigens; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Female; Fibroblasts; Flow Cytometry; Heptanoic Acids; HLA-DR Antigens; Humans; Interleukin-6; Lectins, C-Type; Leukocytes, Mononuclear; Male; Middle Aged; Probability; Pyrroles; Reference Values; Reverse Transcriptase Polymerase Chain Reaction; Synovial Membrane; T-Lymphocyte Subsets; Young Adult | 2009 |
Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial.
Topics: Aged; Anticholesteremic Agents; Arthritis, Rheumatoid; Atorvastatin; Cholesterol; Female; Heptanoic Acids; Humans; Male; Middle Aged; Myocardial Infarction; Pyrroles; Randomized Controlled Trials as Topic; Risk Factors; Simvastatin; Statistics as Topic | 2011 |
Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Atorvastatin; Cells, Cultured; Coculture Techniques; Female; Gene Expression Regulation; Heptanoic Acids; Humans; Male; Osteoclasts; Osteogenesis; Pyrroles; RANK Ligand; Synovial Membrane | 2012 |
Statins in rheumatoid arthritis--two birds with one stone?
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Atorvastatin; Cardiovascular Diseases; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Risk Factors | 2004 |
Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis.
Topics: Adult; Aged; Arteries; Arthritis, Rheumatoid; Atorvastatin; Drug Evaluation; Elasticity; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Lipids; Male; Middle Aged; Pulsatile Flow; Pyrroles; Radial Artery | 2004 |
Rheumatoid arthritis treatment progressing.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Rheumatoid; Atorvastatin; Cyclophosphamide; Drug Therapy, Combination; Heptanoic Acids; Humans; Methotrexate; Pyrroles; Rituximab | 2004 |
Statin-induced expression of CD59 on vascular endothelium in hypoxia: a potential mechanism for the anti-inflammatory actions of statins in rheumatoid arthritis.
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Atorvastatin; CD55 Antigens; CD59 Antigens; Cells, Cultured; Cobalt; Cytoprotection; Deferoxamine; Diterpenes; Endothelial Cells; Endothelium, Vascular; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoxia; Iron Chelating Agents; Mevalonic Acid; Pyrroles; RNA, Messenger; Up-Regulation | 2006 |
Atorvastatine for chronic synovitis due to massive intra-articular cholesterol monohydrate deposition in long-standing rheumatoid arthritis.
Topics: Anticholesteremic Agents; Arthritis, Rheumatoid; Atorvastatin; Cholesterol; Crystallization; Female; Heptanoic Acids; Humans; Middle Aged; Pyrroles; Synovitis | 2006 |
Tolerizing DNA vaccines for autoimmune arthritis.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Atorvastatin; Autoantibodies; Collagen; Cytokines; Heptanoic Acids; Hindlimb; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-4; Joints; Male; Mice; Mice, Inbred DBA; Protein Array Analysis; Pyrroles; Systems Biology; Vaccines, DNA | 2006 |